Health policy experts questioned the efficacy of President Trump's administration's 'most-favored-nation' drug pricing program announced on September 19, with concerns over whether patients will actually benefit. The program aims to involve all 50 states.
No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.
President Trump boasted about his administration’s work on drug pricing, announcing the “most-favored-nation” program, but health policy experts question whether the changes will directly save consumers money.
www.joemygod.com/2026/09/expe... Semafor reports: President Trump took a victory lap on his administration’s work on drug pricing Friday announcing all 50 states will participate in the “most-favored-nation” program, saying “this one...